Intramuscular tetanus neurotoxin reverses muscle atrophy: a randomized controlled trial in dogs with spinal cord injury.
Anna KutschenkoAnja ManigAngelika MönnichBeatrice BrylCécile-Simone AlexanderMartin DeutschlandStefan HesseDavid LiebetanzPublished in: Journal of cachexia, sarcopenia and muscle (2021)
With regard to the beneficial effects on muscle thickness, intramuscular injections of TeNT represent the first pharmacological approach that focally reverses muscle atrophy in SCI. Moreover, the study data support the safety of this treatment when TeNT is used at low dose.